IL6 and COVID-19: Accordingly, recent data on the ratio of the pro-inflammatory cytokine IL-6 and the anti-inflammatory cytokine IL-10 suggested that serum cytokines may be used for risk stratification in hospitalized COVID-19 patients (McElvaney et al., 2020).